Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric oxygen therapy and CDP-choline for sudden idiopathic deafness
2009-011556-22Phase 3Terminated
- Sponsor
- Policlinico di Milano
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citicoline in idiopathic sudden sensorineural hearing loss (ISSNHL), sponsored by Policlinico di Milano. Primary endpoint: Healing of the patients. Started Mar 2010; status: terminated.
02
Drugs
citicoline
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on 2009-011556-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011556-22.